Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Pyridine | HCID 1049 | — |
| Reactant | Morpholine | HCID 8083 | — |
| Reactant | N5-cyclohexyl[1,2,4]triazolo[1,5-a]pyridine-2,5-diamine | HCID 25216186 | — |
| Reactant | HCID 86643869 | HCID 86643869 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 59437496 | HCID 59437496 | 9.2% |
Reaction Steps
Pyridine (198 mg; 2.5 mmol; 5.0 eq.) was added to a solution of N5-cyclohexyl[1,2,4]triazolo[1,5-a]pyridine-2,5-diamine ((A9), 116 mg; 0.50 mmol; 1.0 eq.) in DCM (2.0 mL). 6-(chloromethyl)pyridine-3-carbonyl chloride hydrochloride (190 mg; 1.0 mmol; 2.0 eq.) was added and the resulting black solution was stirred under reflux for 14 h. The solvents were evaporated to yield a black oil. Morpholine (218 mg; 2.5 mmol; 5.0 eq.) and THF (0.5 mL) were added to this residue, and the mixture was then stirred and heated at 60° C. for 12 h. Purification by RP-HPLC (Waters Sunfire™ Prep C18 OBD™ 5 μM, 100×49 mm) following a gradient starting with 20/80 (0.1% formic acid in CH3CN/0.1% formic acid in H2O) up to 95/5 in 12 min. The fractions were collected and lyophilized to give the title compound as a white powder (20 mg, 9%). HPLC, Rt: 2.11 min. (purity 100%). LC/MS, M+(ESI): 436.3.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08263595B2 |
|---|
| Source dataset | uspto-grants-2012_09 |
|---|
| ORD ID | ord-17c9a930b34843bdac828600c9566a35 |
|---|
| Source note | uspto-grants-2012_09 |
|---|